| Ryan Thomas Barrett, MD | |
|
360 E Mallard Dr, Ste 110, Boise, ID 83706-3945 | |
| (208) 336-8700 | |
| (208) 426-0902 |
| Full Name | Ryan Thomas Barrett |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 13 Years |
| Location | 360 E Mallard Dr, Boise, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982994844 | NPI | - | NPPES |
| 805858400 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | M-13360 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hollingshead Eye Center, Pc | 9830133214 | 5 |
News Archive
For patients with inflammatory bowel disease, the possibility of taking a single pill to bring long-lasting relief might seem too good to be true. Scientists at the Lewis Katz School of Medicine at Temple University are on the brink of making that happen, thanks to a recent proof-of-concept study, in which the severity of a form of inflammatory bowel disease in mice was dramatically reduced with one oral dose of a protein isolated from a bacterial biofilm.
The fungus Cryptococcus causes meningitis, a brain disease that kills about 1 million people each year — mainly those with impaired immune systems due to AIDS, cancer treatment or an organ transplant.
The U.S. Food and Drug Administration has announced the approval of the vaccine Gardasil for the prevention of vaginal and vulvar cancer caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women ages 9 to 26.
CorVel Corporation today announced earnings per share of $0.56 for the quarter ended December 31, 2010, a 4% increase compared to $0.54 in the same quarter of the prior fiscal year. Earnings per share for the nine months ended December 31, 2010 were $1.82, a 20% increase over the $1.52 earnings per share for the nine months ended December 31, 2009.
"Scientists on Wednesday unveiled the genome of the soybean, saying it was an achievement that should deepen understanding of one of the world's most important crops, help to boost yields and defend the plant against pests," Agence France-Presse reports. The study, published in the journal Nature, details the findings of the "[e]ighteen organisations, most of them American, [who] teamed up in a 15-year endeavour that yielded a draft of 85 percent of the soybean's 1.1 billion base pairs, the 'rungs' in the double-helix ladder of DNA," the news service writes
› Verified 3 days ago
| Entity Name | Hollingshead Eye Center, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871643585 PECOS PAC ID: 9830133214 Enrollment ID: O20050616000317 |
News Archive
For patients with inflammatory bowel disease, the possibility of taking a single pill to bring long-lasting relief might seem too good to be true. Scientists at the Lewis Katz School of Medicine at Temple University are on the brink of making that happen, thanks to a recent proof-of-concept study, in which the severity of a form of inflammatory bowel disease in mice was dramatically reduced with one oral dose of a protein isolated from a bacterial biofilm.
The fungus Cryptococcus causes meningitis, a brain disease that kills about 1 million people each year — mainly those with impaired immune systems due to AIDS, cancer treatment or an organ transplant.
The U.S. Food and Drug Administration has announced the approval of the vaccine Gardasil for the prevention of vaginal and vulvar cancer caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women ages 9 to 26.
CorVel Corporation today announced earnings per share of $0.56 for the quarter ended December 31, 2010, a 4% increase compared to $0.54 in the same quarter of the prior fiscal year. Earnings per share for the nine months ended December 31, 2010 were $1.82, a 20% increase over the $1.52 earnings per share for the nine months ended December 31, 2009.
"Scientists on Wednesday unveiled the genome of the soybean, saying it was an achievement that should deepen understanding of one of the world's most important crops, help to boost yields and defend the plant against pests," Agence France-Presse reports. The study, published in the journal Nature, details the findings of the "[e]ighteen organisations, most of them American, [who] teamed up in a 15-year endeavour that yielded a draft of 85 percent of the soybean's 1.1 billion base pairs, the 'rungs' in the double-helix ladder of DNA," the news service writes
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Thomas Barrett, MD 360 E Mallard Dr, Ste 110, Boise, ID 83706-3945 Ph: (208) 336-8700 | Ryan Thomas Barrett, MD 360 E Mallard Dr, Ste 110, Boise, ID 83706-3945 Ph: (208) 336-8700 |
News Archive
For patients with inflammatory bowel disease, the possibility of taking a single pill to bring long-lasting relief might seem too good to be true. Scientists at the Lewis Katz School of Medicine at Temple University are on the brink of making that happen, thanks to a recent proof-of-concept study, in which the severity of a form of inflammatory bowel disease in mice was dramatically reduced with one oral dose of a protein isolated from a bacterial biofilm.
The fungus Cryptococcus causes meningitis, a brain disease that kills about 1 million people each year — mainly those with impaired immune systems due to AIDS, cancer treatment or an organ transplant.
The U.S. Food and Drug Administration has announced the approval of the vaccine Gardasil for the prevention of vaginal and vulvar cancer caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women ages 9 to 26.
CorVel Corporation today announced earnings per share of $0.56 for the quarter ended December 31, 2010, a 4% increase compared to $0.54 in the same quarter of the prior fiscal year. Earnings per share for the nine months ended December 31, 2010 were $1.82, a 20% increase over the $1.52 earnings per share for the nine months ended December 31, 2009.
"Scientists on Wednesday unveiled the genome of the soybean, saying it was an achievement that should deepen understanding of one of the world's most important crops, help to boost yields and defend the plant against pests," Agence France-Presse reports. The study, published in the journal Nature, details the findings of the "[e]ighteen organisations, most of them American, [who] teamed up in a 15-year endeavour that yielded a draft of 85 percent of the soybean's 1.1 billion base pairs, the 'rungs' in the double-helix ladder of DNA," the news service writes
› Verified 3 days ago
Dr. Mark J Boerner, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 111 W Main St Ste 200, Boise, ID 83702 Phone: 208-344-3220 Fax: 208-344-0461 | |
James R Swartley, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 222 N 2nd St, Suite 215, Boise, ID 83702 Phone: 208-342-2706 | |
Landon Kelly Grange, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 5680 W Gage St, Boise, ID 83706 Phone: 208-773-3937 Fax: 208-377-3937 | |
Dr. Chad Harman Jackson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 111 W Main St Ste 200, Boise, ID 83702 Phone: 208-344-3220 Fax: 208-344-0461 | |
Daniel R Brooks, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 222 N 2nd St, Ste 215, Boise, ID 83702 Phone: 208-381-6910 | |
John R Sonntag, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 5680 W Gage St, Boise, ID 83706 Phone: 208-377-3937 Fax: 208-377-9455 | |
Ali Torab Parhiz, M.D Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 901 N Curtis Rd Ste 302, Boise, ID 83706 Phone: 812-424-2020 |